ARCHIVES

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998

Medicare Coverage For Clinical Trials Tops NBCC Agenda

January 30, 1998

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003